A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma.
暂无分享,去创建一个
J. Nieva | C. Chung | M. Schell | D. Sidransky | J. Bishop | J. Gilbert | B. Murphy | R. Ravi | Marino E. Leon | M. Haigentz | A. Bedi | T. Tanvetyanon | Xiuhua Zhao | D. Neil Hayes | N. Saba